Mission Bio, Inc., a leader in single-cell multi-omic solutions for precision medicine, announced that its Tapestri Platform and custom assay development supported initial exploratory biomarker ...

Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...

AN ENLIGHTENING session, entitled ‘Emerging therapeutic frontiers in cardiology: what does the future hold?’, delivered at ...

The prospect of diagnosing cancer through painless methods—such as a simple AI-assisted blood or urine test that detects tiny ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

March of Dimes, the national leader in maternal and infant health research, today announced the winners of the 2025 Basil O'Connor Starter Scholar Research Awards, which recognize exceptional ...

Stem cells sent to the ISS return with signs of accelerated aging, revealing key risks for future space travel.

Insilico Medicine (“Insilico”), a global leader in AI-powered drug discovery, and Atossa Therapeutics (“Atossa”) (Nasdaq: ...

Insilico Medicine ("Insilico"), a global leader in AI-powered drug discovery, and Atossa Therapeutics ("Atossa") (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel treatments ...

The 24th HUPO World Congress showed a field growing beyond mass spectrometry and starting to think in terms of impact of its ecosystems.

Insilico Medicine ("Insilico"), a global leader in AI-powered drug discovery, and Atossa Therapeutics ("Atossa") (Nasdaq ...

Atossa Therapeutics (ATOS) and Insilico Medicine, a company dealing in AI-powered drug discovery, announced the publication of a joint study ...